Regeneron Pharmaceuticals used LinkedIn for company presence and plans to present at a Morgan Stanley conference.
3 reports, 1 independent
Updated Sep 1
No new developments lately
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regeneron Pharmaceuticals used LinkedIn for company presence and plans to present at a Morgan Stanley conference.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regeneron Pharmaceuticals
American pharmaceutical company
-
LinkedIn
American social networking website for people in professional occupations
-
Morgan Stanley
U.S. investment bank
Related events
- Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.
- Edgewise Therapeutics announced news from Boulder, Colorado, and utilizes LinkedIn for its public communication.
- BD started using LinkedIn for its company presence in July 2025.
- Nasdaq directs interested parties to LinkedIn for company information.
- Lenovo uses LinkedIn for professional announcements, and a staff member transitioned from Parle Agro to the company.
Coverage
Newest first; wire copies grouped- GlobeNewswireRegeneron Announces Updated Presentation Time for Upcoming Investor Conference TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that
- GlobeNewswireRegeneron Announces Investor Conference Presentations TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follow